To learn about Sanofi's efforts in the fight against COVID-19, click here.
Those living with multiple sclerosis (MS) and their loved ones may be facing a lot of uncertainty during this pandemic. We are committed to keeping the communities we serve updated with information that could help inform health decisions. At this time, we recognize that there are many questions regarding the impact of the COVID-19 on MS patients, or regarding this virus and any specific MS disease-modifying therapy (DMT). We are actively engaging the global MS community to learn more about COVID-19, as well as any potential considerations for AUBAGIO® (teriflunomide).
As always, your healthcare provider is the best resource for medical advice and any questions you may have. Speak with your healthcare provider before making any change to your treatment regimen and discuss the potential benefits and the risks of taking AUBAGIO.
You can have confidence that MS One to One provides nurse support 24/7—whether you're a person living with MS or a support partner; if you're on AUBAGIO or taking something else.
MS One to One Nurses can help your patients in many ways including:
If you are on Aubagio, MS One to One nurses can help you by:
Contact an MS One to One nurse anytime, day or night. Visit the MS One To One page or call to learn more.
Stream our relapsing MS On Demand webinars anytime. Watch in-depth discussions with MS experts designed to help you keep learning about your condition – and once-daily AUBAGIO. To learn more or to register for an event, go to our events page.
The health and safety of our patients is and always will be our highest priority. We will continue to closely monitor this situation which has affected so many across the globe.
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Are of childbearing potential and not using effective birth control.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), over-the-counter medicines, vitamins or herbal supplements.
AUBAGIO may cause serious side effects. Tell your doctor if you have any of the following:
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
IMPORTANT SAFETY INFORMATION
Do not take AUBAGIO if you have severe liver problems. AUBAGIO may cause serious liver problems, including liver failure that can be life-threatening and may require a liver transplant. View More